Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.
about
Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.Wnt signaling in castration-resistant prostate cancer: implications for therapy.The role of TWIST1 in epithelial-mesenchymal transition and cancers.miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin.Inhibition of cyclin D1 enhances sensitivity to radiotherapy and reverses epithelial to mesenchymal transition for esophageal cancer cells.Stat3-siRNA inhibits the growth of gastric cancer in vitro and in vivo.Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.Mitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expression.TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.Prognostic value of differential CCND1 expression in patients with resected gastric adenocarcinoma.v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1.Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer.Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth.Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome.Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
P2860
Q36511748-0512456A-CC27-4814-93DD-29CBEEAF3A75Q37636676-F280B1EA-7D23-458E-A328-7AA89D66F4A9Q38241850-ED0D96B4-E71E-4981-81D3-260FDC8E9D1FQ38646345-52A93701-65AF-41EB-B69C-C0E26E04D600Q38766169-5F87294C-9ECE-467A-91C6-7B2377CE1A7CQ38819981-5B83F6A0-2058-4996-84C1-E134BA7E1524Q38826310-4585C49D-33C0-4912-9BD2-1FFB2E6034E0Q38895320-B9822A8F-67D3-48B3-A85F-5B0F0BECCDAFQ38912201-10DB1DD6-5BDA-4C6F-9BA8-011EEEFE9B70Q39626323-FF21A9CE-3BA7-4728-A2AD-2D994EEEB8D5Q40862939-D11630FF-6C93-4416-9E82-92F56932529DQ41752546-651ACC41-E673-4918-9EDA-4E26FABC0D58Q43931330-4A1C6C8F-386D-4FDB-ACA2-38C504676CDAQ44420270-3DE3FB7C-2333-43EC-9E76-0C8CCF49B55FQ45226905-A5D25F96-C29C-4DBA-97E3-8E067FDDE220Q52714385-2F4B68A2-475B-4613-8E8D-E8ECCBFA38BDQ53760324-FC1D033A-758A-461A-AD74-7EDC4F8D6230
P2860
Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Identification of a cyclin D1 ...... thelial-mesenchymal restraint.
@en
Identification of a cyclin D1 ...... thelial-mesenchymal restraint.
@nl
type
label
Identification of a cyclin D1 ...... thelial-mesenchymal restraint.
@en
Identification of a cyclin D1 ...... thelial-mesenchymal restraint.
@nl
prefLabel
Identification of a cyclin D1 ...... thelial-mesenchymal restraint.
@en
Identification of a cyclin D1 ...... thelial-mesenchymal restraint.
@nl
P2093
P2860
P1433
P1476
Identification of a cyclin D1 ...... thelial-mesenchymal restraint.
@en
P2093
Adam Ertel
Andrew A Quong
Marco Crosariol
Mathew C Casimiro
Michael Gormley
Richard G Pestell
Sanjay Katiyar
P2860
P304
P356
10.1158/0008-5472.CAN-13-1313
P407
P577
2013-11-26T00:00:00Z